Showing results (351-360 of 502) with videos related to
Sort By:
Pageof 51
Journal of the American College of Cardiology|June 12, 2010
A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndromeRon Waksman, Rebecca Torguson, Kenneth M Kent, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 12, 2009
Impact of intravascular ultrasound guidance in patients with acute myocardial infarction undergoing percutaneous coronary interventionGabriel Maluenda, Gilles Lemesle, Itsik Ben-Dor, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 6, 2005
Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapyPramod Kuchulakanti, Roswitha Wolfram, Rebecca Torguson, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 21, 2007
Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stentShaila Garg, Kimberly Smith, Rebecca Torguson, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 3, 2005
Three-year follow-up after intravascular gamma-radiation for in-stent restenosis in saphenous vein graftsSeung-Woon Rha, Pramod Kuchulakanti, Andrew E Ajani, et al.The American Journal of Cardiology|April 9, 2013
Two-year follow-up of outcomes of second-generation everolimus-eluting stents versus first-generation drug-eluting stents for stenosis of saphenous vein grafts used as aortocoronary conduitsHironori Kitabata, Joshua P Loh, Lakshmana K Pendyala, et al.The American Journal of Cardiology|April 19, 2011
Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stentsMichael Mahmoudi, Cedric Delhaye, Kohei Wakabayashi, et al.The American Journal of Cardiology|February 5, 2004
Usefulness of periprocedural creatinine phosphokinase-MB release to predict adverse outcomes after intracoronary radiation therapy for in-stent restenosisAndrew E Ajani, Ron Waksman, Arvind K Sharma, et al.The American Journal of Cardiology|October 15, 2003
Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventionsTimothy D Kinnaird, Eugenio Stabile, Gary S Mintz, et al.The American Journal of Cardiology|July 6, 2013
Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stentsHironori Kitabata, Joshua P Loh, Lakshmana K Pendyala, et al.Pageof 51